First Horizon Advisors, Inc. Apellis Pharmaceuticals, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.58 Billion
- Q3 2024
A detailed history of First Horizon Advisors, Inc. transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 863 shares of APLS stock, worth $29,281. This represents 0.0% of its overall portfolio holdings.
Number of Shares
863
Previous 896
3.68%
Holding current value
$29,281
Previous $34,000
29.41%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding APLS
# of Institutions
309Shares Held
115MCall Options Held
3.85MPut Options Held
1.09M-
Wellington Management Group LLP Boston, MA15.6MShares$528 Million0.08% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$403 Million14.88% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$377 Million4.82% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.82MShares$333 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$197 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $3.73B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...